Study could pave the way for routine eyecare imaging as a disease screening tool

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes, dementia and multiple sclerosis.

BioNTech licenses MediLink’s anti-cancer antibody-drug conjugate – Pharmaceutical Technology

BioNTech also has a licensing agreement with Duality Biologics to develop multiple antibody-drug conjugates. Credit: Tobias Arhelger/Shutterstock. BioNTech has entered into a licencing agreement with

October 13, 2023

Genfit, Ipsen tout pivotal trial readout for rare liver disease, head toward FDA and EMA submissions

Genfit and Ipsen announced Friday morning that their experimental treatment elafibranor helped patients with primary biliary cholangitis, a rare liver disease, see a decrease in

July 1, 2023

Defender’s plans for motion sickness nasal gel stop with FDA rejection – Pharmaceutical Technology

Share this article Nasa is helping with Defender’s development of DPI-386, as astronauts are particularly susceptible to motion sickness in space. Image credit: Shutterstock/Supamotionstock.com. The

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.